S

Surgalign Holdings Inc
F:RT2

Watchlist Manager
Surgalign Holdings Inc
F:RT2
Watchlist
Price: 3.03 EUR -2.73% Market Closed
Market Cap: 20.1m EUR

Surgalign Holdings Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Surgalign Holdings Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgalign Holdings Inc
F:RT2
Cash from Operating Activities
-$42m
CAGR 3-Years
N/A
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Cash from Operating Activities
$289m
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
9%
ICU Medical Inc
NASDAQ:ICUI
Cash from Operating Activities
$159.4m
CAGR 3-Years
93%
CAGR 5-Years
-4%
CAGR 10-Years
10%
Align Technology Inc
NASDAQ:ALGN
Cash from Operating Activities
$656m
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Operating Activities
$457.7m
CAGR 3-Years
34%
CAGR 5-Years
64%
CAGR 10-Years
56%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash from Operating Activities
$267.6m
CAGR 3-Years
27%
CAGR 5-Years
11%
CAGR 10-Years
13%
No Stocks Found

Surgalign Holdings Inc
Glance View

Market Cap
20.1m EUR
Industry
Health Care

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.

RT2 Intrinsic Value
Not Available

See Also

What is Surgalign Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
-42m USD

Based on the financial report for Mar 31, 2023, Surgalign Holdings Inc's Cash from Operating Activities amounts to -42m USD.

What is Surgalign Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-37%

Over the last year, the Cash from Operating Activities growth was 26%.

Back to Top